Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
+3.61M
-
Total reported value, excl. options
-
$406M
-
Value change
-
+$55.8M
-
Number of buys
-
43
-
Number of sells
-
-33
-
Price
-
$15.43
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q4 2022
88 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q4 2022.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 104M outstanding shares and own 25.34% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (5.47M shares), BANK OF AMERICA CORP /DE/ (2.53M shares), Saba Capital Management, L.P. (2.47M shares), Cornerstone Advisors, LLC (2.18M shares), UBS Group AG (2.13M shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (1.57M shares), 1607 Capital Partners, LLC (1.52M shares), WELLS FARGO & COMPANY/MN (987K shares), RAYMOND JAMES & ASSOCIATES (845K shares), and Karpus Management, Inc. (772K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.